Navea L[au] - Search Results

Year	Number of Results
1992	1
1996	3
1997	1
1999	1
2001	2
2004	1
2005	1
2011	1
2013	2
2016	1
2023	0

1

Safety of the production process of SURFACEN(®) to inactivate and remove virus.

Sánchez Y, Noa E, Alfonso W, Dubed M, Alvarez G, Navea L, Montes de Oca N, Lobaina L, Díaz E. Sánchez Y, et al. Among authors: navea l. Biologicals. 2013 Jul;41(4):254-60. doi: 10.1016/j.biologicals.2013.04.003. Epub 2013 May 9. Biologicals. 2013. PMID: 23665304

2

Identification of Vimentin as a Potential Therapeutic Target against HIV Infection.

Fernández-Ortega C, Ramírez A, Casillas D, Paneque T, Ubieta R, Dubed M, Navea L, Castellanos-Serra L, Duarte C, Falcon V, Reyes O, Garay H, Silva E, Noa E, Ramos Y, Besada V, Betancourt L. Fernández-Ortega C, et al. Among authors: navea l. Viruses. 2016 Jun 15;8(6):98. doi: 10.3390/v8060098. Viruses. 2016. PMID: 27314381 Free PMC article.

3

Validation of model virus removal and inactivation capacity of an erythropoietin purification process.

Pérez M, Rodríguez E, Rodríguez M, Paez R, Ruibal I, Noa E, García O, Moya G, Martínez M, Marcelo J, Martínez A, Dubal M, Navea L, Valdés R. Pérez M, et al. Among authors: navea l. Biologicals. 2011 Nov;39(6):430-7. doi: 10.1016/j.biologicals.2011.09.006. Epub 2011 Oct 8. Biologicals. 2011. PMID: 21982851

4

Non-induced leukocyte extract reduces HIV replication and TNF secretion.

Fernández-Ortega C, Dubed M, Ramos Y, Navea L, Alvarez G, Lobaina L, López L, Casillas D, Rodríguez L. Fernández-Ortega C, et al. Among authors: navea l. Biochem Biophys Res Commun. 2004 Dec 17;325(3):1075-81. doi: 10.1016/j.bbrc.2004.10.142. Biochem Biophys Res Commun. 2004. PMID: 15541398

5

Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay.

Vödrös D, Tscherning-Casper C, Navea L, Schols D, De Clercq E, Fenyö EM. Vödrös D, et al. Among authors: navea l. Virology. 2001 Dec 5;291(1):1-11. doi: 10.1006/viro.2001.1163. Virology. 2001. PMID: 11878871 Free article.

6

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1).

Montero M, Menéndez A, Domínguez MC, Navea L, Vilarubia OL, Quintana D, Izquierdo M, Jiménez V, Reyes O, Lobaina L, Noa E, Duarte CA. Montero M, et al. Among authors: navea l. Vaccine. 1997 Aug;15(11):1200-8. doi: 10.1016/s0264-410x(97)00012-1. Vaccine. 1997. PMID: 9286044

7

Phylogenetic analysis of human T cell lymphotropic virus type 1 isolated from Cuban individuals.

Machado LY, Navea LM, Díaz HM, Blanco M, Dubed M, Romay DM, Silva E, Pérez LJ. Machado LY, et al. Among authors: navea lm. AIDS Res Hum Retroviruses. 2013 Aug;29(8):1168-72. doi: 10.1089/AID.2012.0225. Epub 2013 May 15. AIDS Res Hum Retroviruses. 2013. PMID: 23601028

8

High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris.

Farnós O, Boué O, Parra F, Martín-Alonso JM, Valdés O, Joglar M, Navea L, Naranjo P, Lleonart R. Farnós O, et al. Among authors: navea l. J Biotechnol. 2005 May 25;117(3):215-24. doi: 10.1016/j.jbiotec.2005.01.013. J Biotechnol. 2005. PMID: 15862351

9

A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers.

Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Míguez J, Serrano T, Sierra B, Pérez L, Ricardo ME, Dubed M, Lubián AL, Blanco M, Millán JC, Ortega A, Iglesias E, Pentón E, Martín Z, Pérez J, Díaz M, Duarte CA. Toledo H, et al. Among authors: navea l. Vaccine. 2001 Jul 20;19(30):4328-36. doi: 10.1016/s0264-410x(01)00111-6. Vaccine. 2001. PMID: 11457560 Clinical Trial.

10

Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop.

Duarte CA, Pérez L, Vázquez J, Dueñas M, Vilarrubia OL, Navea L, Valdés R, Reyes O, Montero M, Ayala M, Gavilondo J. Duarte CA, et al. Among authors: navea l. Immunotechnology. 1996 Feb;2(1):11-20. doi: 10.1016/1380-2933(95)00024-0. Immunotechnology. 1996. PMID: 9373324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results